387517004: Paracetamol (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Non-opioid analgesic (substance)\Paracetamol

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\...

\Amine and/or amine derivative\Amine\Aniline\Para-aminophenol derivative\Paracetamol

\Amide and/or amide derivative (substance)\Amide\Acetamide and/or acetamide derivative\Acetamide (substance)\Paracetamol

\Organic compound\Organic cyclic compound\Substance with phenol structure\Paracetamol
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Aniline\Para-aminophenol derivative\Paracetamol
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Acetamide and/or acetamide derivative\Acetamide (substance)\Paracetamol

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Paracetamol	Is a	analgésique et antipyrétique	false	Inferred relationship	Some
Paracetamol	Is a	classe d'allergènes	false	Inferred relationship	Some
Paracetamol	Is a	Paracetamol or paracetamol derivative	false	Inferred relationship	Some
Paracetamol	Is a	Para-aminophenol derivative anti-inflammatory agent	false	Inferred relationship	Some
Paracetamol	Is a	Phenol and derivatives	false	Inferred relationship	Some
Paracetamol	Is a	Amide	false	Inferred relationship	Some
Paracetamol	Is a	Drug allergen by structure	false	Inferred relationship	Some
Paracetamol	Is a	Para-aminophenol derivative	true	Inferred relationship	Some
Paracetamol	Is a	Non-opioid analgesic (substance)	true	Inferred relationship	Some
Paracetamol	Is a	Acetamide (substance)	true	Inferred relationship	Some
Paracetamol	Is a	Phenol	false	Inferred relationship	Some
Paracetamol	Is a	Substance with phenol structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Product containing precisely diphenhydramine 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely diphenhydramine 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	2
Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	3
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	1
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Butalbital 50 mg and paracetamol 325 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Butalbital 50 mg and paracetamol 325 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	1
Codeine phosphate 15 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Codeine phosphate 15 mg and paracetamol 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Oxycodone hydrochloride 7.5 mg and paracetamol 325 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Oxycodone hydrochloride 7.5 mg and paracetamol 325 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	3
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	3
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	2
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	2
Product containing orphenadrine and paracetamol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paracetamol	Inferred relationship	Some	2
Product containing caffeine and codeine and paracetamol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paracetamol	Inferred relationship	Some	3
Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	2
Product containing caffeine and codeine and paracetamol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paracetamol	Inferred relationship	Some	3
Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	2
Product containing precisely paracetamol 120 milligram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some
Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some
Acetaminophen+dextropropoxyphene hydrochloride 325mg/32.5mg/5mL conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paracetamol	Inferred relationship	Some
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1
Product containing precisely paracetamol 500 milligram/1 each conventional release rectal suppository (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	1
Product containing precisely paracetamol 500 milligram/1 each conventional release rectal suppository (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paracetamol	Inferred relationship	Some	1
Paracetamol 240 mg rectal suppository	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	1
Paracetamol 240 mg rectal suppository	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paracetamol	Inferred relationship	Some	1
Product containing precisely paracetamol 120 milligram/1 each conventional release rectal suppository (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paracetamol	Inferred relationship	Some	1
Product containing precisely paracetamol 120 milligram/1 each conventional release rectal suppository (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	1
Paracetamol 250 mg rectal suppository	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	1
Paracetamol 250 mg rectal suppository	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paracetamol	Inferred relationship	Some	1
Paracetamol 60 mg rectal suppository	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	1
Paracetamol 60 mg rectal suppository	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paracetamol	Inferred relationship	Some	1
Product containing precisely paracetamol 125 milligram/1 each conventional release rectal suppository (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paracetamol	Inferred relationship	Some	1
Product containing precisely paracetamol 125 milligram/1 each conventional release rectal suppository (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paracetamol	Inferred relationship	Some	1
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paracetamol	Inferred relationship	Some	1

Start Previous Page 5 of 11 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1481607015	Acetaminophen	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492140010	Paracetamol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3482728017	Paracetamol (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
51591000195119	paracetamolo	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
831131000172117	paracétamol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
65861000195116	Paracetamol	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
235861000195117	Acetaminophen	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module